WELLINGTON MANAGEMENT CO LLP 13D and 13G filings for Olema Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-06 2:56 pm Sale |
2022-12-30 | 13G | Olema Pharmaceuticals, Inc. OLMA |
WELLINGTON MANAGEMENT CO LLP | 0 0.000% |
-2,019,109 (Position Closed) |
Filing |
| 2022-02-04 09:21 am Sale |
2021-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA |
WELLINGTON MANAGEMENT CO LLP | 2,019,109 5.010% |
-50,206 (-2.43%) |
Filing |
| 2021-02-04 09:51 am Purchase |
2020-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA |
WELLINGTON MANAGEMENT CO LLP | 2,069,315 5.150% |
2,069,315 (New Position) |
Filing |